Public health authorities in the Democratic Republic of Congo have reported that confirmed Ebola cases have surged to 10,060, with the death toll climbing to 4,887 since the outbreak was first identified in mid-May. The Africa Centres for Disease Control and Prevention has characterized this crisis as the fastest-growing Ebola outbreak in recorded history.

The current outbreak is driven by the Bundibugyo virus strain, for which there is currently no approved vaccine or specific treatment available, severely complicating containment efforts. Early symptoms frequently mimic those of malaria, which can dangerously delay proper patient isolation, diagnosis, and medical intervention.

The contagion has already spilled across national borders. Kenya has confirmed nine infections, including two deaths, following the movement of an infected traveler from DR Congo through Uganda to Nairobi. Additionally, Nigeria reported an infection in a foreign national who had traveled through the region before being evacuated to Switzerland.

International and local health agencies are desperately searching for solutions, with clinical trials for two antiviral treatments underway since July. Furthermore, researchers are investigating whether the existing Ervebo vaccine—traditionally approved only for the Zaire ebolavirus strain—can offer protection against the Bundibugyo variant.

Source: www.dw.com